Invention Grant
- Patent Title: Myostatin isoform
- Patent Title (中): 肌生成抑制素同种型
-
Application No.: US13085263Application Date: 2011-04-12
-
Publication No.: US08455448B2Publication Date: 2013-06-04
- Inventor: Ferenc Jeanplong , Christopher David McMahon
- Applicant: Ferenc Jeanplong , Christopher David McMahon
- Applicant Address: AU Victoria
- Assignee: Myostin Therapeutics Pty Ltd
- Current Assignee: Myostin Therapeutics Pty Ltd
- Current Assignee Address: AU Victoria
- Agency: Knobbe Martens Olson & Bear LLP
- Priority: NZ535696 20040930; NZ538396 20050222
- Main IPC: A61K38/10
- IPC: A61K38/10 ; A61K38/16 ; A61K35/34 ; A61P21/00

Abstract:
The present invention provides splice variants of myostatin that promote muscle growth, and include polynucleotides and polypeptide sequences, constructs comprising the sequences and compositions for regulating muscle growth and treating diseases associated with muscle tissue. The splice variants include the consensus sequence X1 I F L E X2 X3 X4 Q X5 C S I L X6 X7 X8 X9 X10 wherein X1 is I or L, X2 is V or L, X3 is Y, C, G or S, X4 is I or F, X5 is F or L, X6 is G or E, X7 is E or V, X8 is A or T, X9 is A or V and X10 is absent, F or L. The present invention also provides for the use of the present sequences in identifying animals with altered muscle mass, and for use in selective breeding programs to produce animals with altered muscle mass.
Public/Granted literature
- US20110258712A1 MYOSTATIN ISOFORM Public/Granted day:2011-10-20
Information query
IPC分类: